Abstract: Extensive research has been conducted to explore cryptographic API misuse in Java. However, despite the tremendous popularity of the Python language, uncovering similar issues has not been ...

Perimenopausal women face increased pregnancy-related risks, necessitating continued contraceptive use until menopause is confirmed. Healthy women can use combination hormonal contraceptives until mid ...

String manipulation is a core skill for every Python developer. Whether you’re working with CSV files, log entries, or text analytics, knowing how to split strings in Python makes your code cleaner ...

When writing or testing Python scripts, your terminal can quickly become cluttered with logs, debug messages, and outputs. A clean console not only improves readability but also helps you stay focused ...

The challenge takes place from July 11-20 in designated South Florida locations. Participants compete for prizes, including $10,000 for removing the most pythons. Pythons must be killed humanely using ...

Background: Failure to detect significant drug interactions may result in adverse outcomes. While proper screening and management of drug interactions can prevent the majority of adverse events, ...

Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. In what researchers hope could be a case of 1 + ...

Don’t like having your period? Hormonal birth control can be used for more than just preventing pregnancy — it’s also a popular way to go months or even years without a period. Continuous use birth ...

A new 3D 'atlas' of the mouse brain promises to sharpen scientists' ability to measure brain changes and share findings across studies of diseases like Alzheimer's. The mouse brain atlas combines ...

Abstract: In this article, we introduce a convex combination-based distributed momentum method (CDM) for solving distributed optimization to minimize a sum of smooth and strongly convex local ...

Dose finding study of CBM588 in combination with nivolumab and ipilimumab in patients with metastatic renal cell carcinoma: A phase I study. This is an ASCO Meeting Abstract from the 2025 ASCO ...